LakeShore Biopharma Valuation
| LSB Stock | 2.75 0.23 7.72% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. LakeShore Biopharma Co, secures a last-minute Real Value of USD2.64 per share. The latest price of the firm is USD2.75. Our model forecasts the value of LakeShore Biopharma Co, from analyzing the firm fundamentals such as Profit Margin of (0.76) %, return on equity of -0.66, and Current Valuation of 139.31 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting LakeShore Biopharma's valuation include:
Price Book 1.3909 | Enterprise Value 139.3 M | Price Sales 0.1993 | Enterprise Value Revenue 1.7295 |
Overvalued
Today
Please note that LakeShore Biopharma's price fluctuation is extremely dangerous at this time. Calculation of the real value of LakeShore Biopharma Co, is based on 3 months time horizon. Increasing LakeShore Biopharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since LakeShore Biopharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of LakeShore Stock. However, LakeShore Biopharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.75 | Real 2.64 | Hype 2.71 | Naive 2.77 |
The real value of LakeShore Stock, also known as its intrinsic value, is the underlying worth of LakeShore Biopharma Co, Company, which is reflected in its stock price. It is based on LakeShore Biopharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of LakeShore Biopharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of LakeShore Biopharma Co, helps investors to forecast how LakeShore stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of LakeShore Biopharma more accurately as focusing exclusively on LakeShore Biopharma's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use LakeShore Biopharma's intrinsic value based on its ongoing forecasts of LakeShore Biopharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against LakeShore Biopharma's closest peers. If more than one evaluation category is relevant for LakeShore Biopharma we suggest using both methods to arrive at a better estimate.
LakeShore Biopharma Cash |
|
LakeShore Valuation Trend
Comparing LakeShore Biopharma's enterprise value against its market capitalization is a good way to estimate the value of LakeShore Biopharma Co, uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
LakeShore Biopharma Total Value Analysis
LakeShore Biopharma Co, is now projected to have company total value of 139.31 M with market capitalization of 114.29 M, debt of 424.46 M, and cash on hands of . Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the LakeShore Biopharma fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
139.31 M | 114.29 M | 424.46 M |
LakeShore Biopharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. LakeShore Biopharma has an asset utilization ratio of 37.9 percent. This suggests that the Company is making USD0.38 for each dollar of assets. An increasing asset utilization means that LakeShore Biopharma Co, is more efficient with each dollar of assets it utilizes for everyday operations.LakeShore Biopharma Ownership Allocation
LakeShore Biopharma Co, maintains a total of 190.81 Million outstanding shares. LakeShore Biopharma Co, secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 81.34 % of LakeShore Biopharma Co, outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.LakeShore Biopharma Profitability Analysis
The company reported the last year's revenue of 573.42 M. Reported Net Loss for the year was (433.46 M) with profit before taxes, overhead, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates LakeShore Biopharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in LakeShore Biopharma and how it compares across the competition.
About LakeShore Biopharma Valuation
The stock valuation mechanism determines LakeShore Biopharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of LakeShore Biopharma. We calculate exposure to LakeShore Biopharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of LakeShore Biopharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 455.7 M | 432.5 M | |
| Pretax Profit Margin | (0.79) | (0.83) | |
| Operating Profit Margin | (0.78) | (0.82) | |
| Net Loss | (0.76) | (0.79) | |
| Gross Profit Margin | 0.79 | 0.62 |
LakeShore Biopharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 106.9 M |
LakeShore Biopharma Current Valuation Indicators
Valuation refers to the process of determining the present value of LakeShore Biopharma Co, and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value LakeShore we look at many different elements of the entity such as LakeShore's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as LakeShore Biopharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use LakeShore Biopharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes LakeShore Biopharma's worth.Complementary Tools for LakeShore Stock analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |